TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
COAG

Hemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

30.60$ -1.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet COAG
Line item Q1 26 Q2 26
100.0% 100.0%
96.7% 99.2%
28.4% 50.7%
93.3% 97.8%
0.8% –
213.3% 2.9%
7.5% 2.8%
0.3% 0.1%
3.2% 1.3%
-113.3% 97.1%
-116.7% -48.9%
25.2% 6.4%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?